BioCorteX
BioCorteX is a tech bio company developing precision medicine solutions using AI-powered in-silico simulations to understand drug-bacteria interactions and personalize treatments.
About
BioCorteX is a pioneering biotech company that leverages its 'Unified Biology' approach and advanced technology platform to transform drug discovery and development. Their Carbon Mirror™ platform, a foundational biology emulator, uses a vast knowledge graph of microbiome samples and AI to conduct in-silico trials, predicting drug-bacteria interactions and optimizing treatment responses for various diseases. This aims to de-risk clinical trials, increase success rates, and deliver personalized therapies to patients worldwide.
Key facts
- Website
- biocortex.com
- Headquarters
- London, United Kingdom
- Founded
- 2021
- Total funding
- $5M (Seed)
- Valuation
- Private
- Business model
- B2B
- Tags
- Artificial IntelligenceBiotechMedTechHealthTechDrug Discovery
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 28 Mar 2023 | Seed | $5M | Sofinnova Partners, Hoxton Ventures |
Tech stack
Detected on biocortex.com, last scanned 21 Sept 2026. Run your own scan
- Email provider
- Google Workspace
Frequently asked
Is BioCorteX trustworthy and reputable?
StartupHub's Data Trust & Reputation score for BioCorteX is 52 out of 100, based on site security posture and privacy practices.
How much funding has BioCorteX raised?
BioCorteX has raised a total of $5M in funding. The most recent round on record is Seed.